Literature DB >> 3282960

Regulation of protein kinase C activity by lipids.

R R Rando1.   

Abstract

Protein kinase C is activated by the simultaneous presence of phospholipid, a diglyceride, and Ca2+. Under physiological conditions the activity of the enzyme is regulated by the availability of diglycerides, which are the products of phosphoinositide hydrolysis. The phospholipid-kinase interactions appear not to be of a highly specific nature. Phosphatidylserine (PS) is presumed to be the endogenous lipid that interacts with the kinase, but other acidic lipids can substitute. On the other hand, the kinase-diglyceride interactions are highly specific in nature, as would be expected of a physiological regulator. These interactions are stereo-specific and stoichiometric with respect to diglyceride. The specificity is directed toward the glycerol backbone and hydrophilic oxygen moieties of the diglyceride. The removal of one or more of the oxygen atoms or the addition of a single methyl group to the glycerol backbone virtually abolishes the activity of a putative diglyceride activator. The extreme specificity of the kinase toward the diglycerides, however, must be contrasted with the abilities of structurally diverse tumor promotors and irritants to activate the kinase. Specific small-molecule antagonists of protein kinase C have yet to be developed. The small-molecule antagonists that have been developed so far have been relatively nonspecific cationic lipids that appear to function by interfering with the interaction between the acidic phospholipids and Ca2+.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282960     DOI: 10.1096/fasebj.2.8.3282960

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  20 in total

Review 1.  Activation and regulation of protein kinase C enzymes.

Authors:  G L Nelsestuen; M D Bazzi
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

2.  The pharmacophore of debromoaplysiatoxin responsible for protein kinase C activation.

Authors:  F H Kong; Y Kishi; D Perez-Sala; R R Rando
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  Unsaturated fatty acids activate glycogen phosphorylase in cultured rat hepatocytes.

Authors:  A Gomez-Muñoz; P Hales; D N Brindley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  Composition of mouse peritoneal macrophage phospholipid molecular species.

Authors:  C C Akoh; R S Chapkin
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

5.  Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma.

Authors:  P Bougnoux; V Chajes; M Lanson; K Hacene; G Body; C Couet; O Le Floch
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

Review 6.  Recent advances in receptor research.

Authors:  M Schachter
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

7.  Interaction of RecA protein with acidic phospholipids inhibits DNA-binding activity of RecA.

Authors:  P Krishna; J H van de Sande
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

8.  1-O-alkyl-2-acetyl-sn-glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells.

Authors:  L L Stoll; P H Figard; N R Yerram; M A Yorek; A A Spector
Journal:  Cell Regul       Date:  1989-11

9.  Calcium stimulates luteinizing-hormone (lutropin) exocytosis by a mechanism independent of protein kinase C.

Authors:  P A van der Merwe; R P Millar; J S Davidson
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

10.  A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage.

Authors:  Karsten Gronert; Alpdogan Kantarci; Bruce D Levy; Clary B Clish; Sabine Odparlik; Hatice Hasturk; John A Badwey; Sean P Colgan; Thomas E Van Dyke; Charles N Serhan
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.